Gallbladder abnormalities octreotide

Avila NA, Shawker TH, Roach P, Bradford MH, Skarulis MC, Eastman R. Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy incidence and time course. J Clin Ultrasound 1998 26(6) 289-94. 

Biliary tract Nine subjects with Prader-Willi syndrome (mean age 15 years) received either octreotide 30 mg or saline intramuscularly every 4 weeks for 16 weeks. After a 24-week wash-out period, they then received the alternative therapy. Three developed gallbladder abnormalities on ultrasound by the end of the octreotide phase two went on to have cholecystectomy 12-24 months later [39 ]. 

---